Page 105 - 南京医科大学学报自然科学版
P. 105
第42卷第4期 孙 伟,于 跃,李 俊,等. 可切除的肺浸润性黏液腺癌的临床特点和预后分析[J].
2022年4月 南京医科大学学报(自然科学版),2022,42(4):549-555 ·555 ·
cinoma:prognostic subgroups and implications for further [18] SHIMIZU K,OKITA R,SAISHO S,et al. Clinicopatholog⁃
revision of staging based on analysis of 514 stage I cases ical and immunohistochemical features of lung invasive
[J]. Mod Pathol,2011,24(5):653-664 mucinous adenocarcinoma based on computed tomogra⁃
[8] CADRANEL J,QUOIX E,BAUDRIN L,et al. IFCT⁃0401 phy findings[J]. Oncotargets Ther,2017,10:153-163
trial:a phase II study of gefitinib administered as first ⁃ [19] CHA Y J,KIM H R,LEE H J,et al. Clinical course of
line treatment in advanced adenocarcinoma with bronchio⁃ stage IV invasive mucinous adenocarcinoma of the lung
loalveolar carcinoma subtype[J]. J Thorac Oncol,2009,4 [J]. Lung Cancer Amsterdam Neth,2016,102:82-88
(9):1126-1135 [20] 留永健,李 霁,王世波,等. 晚期肺炎型肺癌:一项中
[9] MANSUET⁃LUPO A,BOBBIO A,BLONS H,et al. The 国单中心临床⁃放射⁃病理特征回顾性研究及预后分析
new histologic classification of lung primary adenocarci⁃ [J]. 中国肺癌杂志,2019,2(6):329-335
noma subtypes is a reliable prognostic marker and identi⁃ [21] WANG Y D,LIU J C,HUANG C C,et al. Development
fies tumors with different mutation status:the experience and validation of a nomogram for predicting survival of
of a French cohort[J]. Chest,2014,146(3):633-643 pulmonary invasive mucinous adenocarcinoma based on
[10] LEE H Y,CHA M J,LEE K S,et al. Prognosis in resected surveillance,epidemiology,and end results(SEER)data⁃
invasive mucinous adenocarcinomas of the lung:related base[J]. BMC Cancer,2021,21(1):148
factors and comparison with resected nonmucinous adeno⁃ [22] MATSUI T,SAKAKURA N,KOYAMA S,et al. Compari⁃
carcinomas[J]. J Thorac Oncol,2016,11(7):1064-1073 son of surgical outcomes between invasive mucinous and
[11] WATANABE H,SAITO H,YOKOSE T,et al. Relation non ⁃ mucinous lung adenocarcinoma[J]. Ann Thorac
between thin⁃section computed tomography and clinical Surg,2021,112(4):1118-1126
findings of mucinous adenocarcinoma[J]. Ann Thorac [23] 严晓娣,史国振,毛旭华. 高通量测序技术检测非小细
Surg,2015,99(3):975-981 胞肺癌相关驱动基因的突变[J]. 南京医科大学学报
[12] LEE M A,KANG J,LEE H Y,et al. Spread through air (自然科学版),2021,41(2):193-197
spaces(STAS)in invasive mucinous adenocarcinoma of [24] 曲 杨. 肺伴黏液分泌的腺癌分子表型与临床病理特
the lung:Incidence,prognostic impact,and prediction 征和预后相关性研究[D]. 北京:中国人民解放军医学
based on clinicoradiologic factors[J]. Thorac Cancer, 院,2016
2020,11(11):3145-3154 [25] GU R M,SHI Z L,DUAN T,et al. Feasibility and safety
[13]SAITO T,TSUTA K,HONDA O,et al. Prognostic impact of neoadjuvant alectinib in pulmonary invasive mucinous
of mucin spread,tumor cell spread,and invasive size in in⁃ adenocarcinoma with ALK rearrangement:case report
vasive mucinous adenocarcinoma of the lung[J]. Lung and literature review[J]. Oncotargets Ther,2021,14:
Cancer Amsterdam Neth,2020,146:50-57 5107-5113
[14] GOW C H,HSIEH M S,LIU Y N,et al. Clinicopathologi⁃ [26] KADOTA K,YEH Y C,D′ANGELO S P,et al. Associa⁃
cal features and survival outcomes of primary pulmonary tions between mutations and histologic patterns of mucin
invasive mucinous adenocarcinoma[J]. Cancers,2021,13 in lung adenocarcinoma:invasive mucinous pattern and
(16):4103 extracellular mucin are associated with KRAS mutation
[15]OKI T,AOKAGE K,NOMURA S,et al. Optimal method [J]. Am J Surg Pathol,2014,38(8):1118-1127
for measuring invasive size that predicts survival in inva⁃ [27] HONG D S,FAKIH M G,STRICKLER J H,et al.
sive mucinous adenocarcinoma of the lung[J]. J Cancer KRASG12C inhibition with sotorasib in advanced solid
Res Clin Oncol,2020,146(5):1291-1298 tumors[J]. N Engl J Med,2020,383(13):1207-1217
[16] BOLAND J M,MALESZEWSKI J J,WAMPFLER J A,et [28] 温少迪,沈 波. 非小细胞肺癌免疫治疗作用机制及临
al. Pulmonary invasive mucinous adenocarcinoma and 床研究现状[J]. 南京医科大学学报(自然科学版),
mixed invasive mucinous/nonmucinous adenocarcinoma⁃a 2020,40(11):1739-1746
clinicopathological and molecular genetic study with sur⁃ [29] JANG Y J,HYUN D G,CHOI C M,et al. Optimizing pal⁃
vival analysis[J]. Hum Pathol,2018,71:8-19 liative chemotherapy for advanced invasive mucinous ade⁃
[17] LUO J Z,WANG R,HAN B H,et al. Analysis of the clini⁃ nocarcinoma of the lung[J]. BMC Cancer,2021,21(1):
copathologic characteristics and prognostic of stage I inva⁃ 731
sive mucinous adenocarcinoma[J]. J Cancer Res Clin On⁃ [收稿日期] 2021-11-16
col,2016,142(8):1837-1845 (本文编辑:蒋 莉)